PCTC
CRL icon

Perkins Coie Trust Company’s Charles River Laboratories CRL Stock Holding History

Perkins Coie Trust Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60
Closed -$9.03K – 329
2025
Q1 		$9.03K Buy
+60
New +$10.1K ﹤0.01% 252
2023
Q4 		– Sell
-45
Closed -$8.82K – 364
2023
Q3 		$8.82K Buy
+45
New +$9.24K ﹤0.01% 233

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Perkins Coie Trust Company's CRL Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 60 shares — an estimated $9.03K sold.

Perkins Coie Trust Company first reported a position in CRL in Q3 2023 and held it in 2 quarters. The position peaked at $9.03K in Q1 2025. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Perkins Coie Trust Company reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 60 Charles River Laboratories shares in Q2 2025, an estimated $9.03K.
  • Perkins Coie Trust Company first reported a position in Charles River Laboratories in Q3 2023 and held it in 2 quarters.
  • Perkins Coie Trust Company's Charles River Laboratories position peaked at $9.03K in Q1 2025.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.